Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of MK0928 for Insomnia in Adults
NCT00095069Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Oct 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gaboxadol in Insomnia, sponsored by Lundbeck. Started Oct 2004; status: completed.
02
Drugs
gaboxadol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00095069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095069.